Eduovisual
Ethics, Communication & Professionalism
Structural racism and health disparities in clinical practice
— Institutionalized: differential access to goods/services/opportunities by race (e.g., redlining → environmental lead exposure)
— Personally mediated: prejudice and discrimination (assumptions about pain tolerance, adherence)
— Internalized: acceptance by stigmatized groups of negative messages about their own abilities/worth
— Persistent disparate outcome despite guideline-concordant individual care (e.g., Black patient with poorly controlled HTN despite 3-drug regimen — screen for pharmacy desert, copay burden, food insecurity)
— Patterns: maternal mortality 3× higher in non-Hispanic Black women; higher amputation rates in Black diabetics; lower kidney transplant referral; undertreated pain in Black and Hispanic patients
— Geographic clustering of disease (asthma in formerly redlined ZIP codes, elevated BLLs in older housing stock)
Board pearl: When a vignette pairs guideline-concordant care with a worse outcome in a minoritized patient, the answer is rarely "genetic predisposition" — look for a social determinant or systems-level barrier (transportation, insurance, language access, neighborhood exposure) as the correct intervention target.
— Missed appointments → ask about transportation, childcare, hourly wage work, sick leave
— Medication non-adherence → cost, pharmacy access, health literacy, language-concordant labels
— Late-stage cancer diagnosis → screening access, prior insurance lapses, distrust rooted in historical abuses (Tuskegee, Henrietta Lacks, forced sterilizations)
— Uncontrolled asthma in a child → mold/pest/cockroach exposure in substandard housing, proximity to highways
— Postpartum complications dismissed → implicit bias in pain/symptom validation
— Housing: stability, quality, lead paint, mold, overcrowding
— Food: Hunger Vital Sign 2-item screen (sensitivity ~97%)
— Transportation: has it caused a missed visit or prescription pickup?
— Utilities, interpersonal safety, employment, education
— Legal/immigration concerns affecting care-seeking
— Experiences of discrimination in healthcare (validated EDS scale)
— Use trauma-informed, patient-centered language; avoid blaming ("non-compliant" → "barriers to adherence")
— Ask permission: "Is it OK if I ask about some things outside the clinic that affect health?"
— Teach-back to confirm understanding; use professional interpreters (not family) for LEP patients — required under Title VI of the Civil Rights Act
Key distinction: "Non-adherence" is a symptom, not a diagnosis. The Step 3 task is to identify the modifiable upstream cause (cost, access, trust, language) and intervene — not to label the patient. A correct answer often involves connecting to a community health worker, social worker, or patient navigator rather than escalating pharmacotherapy.
— Pulse oximetry overestimates SaO2 in patients with darker skin (occult hypoxemia ~3× more common in Black vs White ICU patients) → confirm with ABG when clinically discordant; do not rely solely on SpO2 to wean oxygen
— Skin findings: erythema, cyanosis, jaundice harder to detect on darker skin — examine palms, soles, conjunctiva, oral mucosa, nail beds; describe morphology, not just color
— Dermatology dataset bias: melanoma, Lyme erythema migrans, drug reactions underrepresented in training images on darker skin → maintain higher index of suspicion
— Pressure injuries: Stage 1 often missed in darker skin; palpate for warmth, induration, boggy tissue
— Insurance status, primary language, pharmacy distance, food access, housing stability
— Neighborhood-level data: Area Deprivation Index, Social Vulnerability Index can be linked to ZIP code in the EHR
— Black patients are systematically undertreated for acute and chronic pain (sickle cell, postoperative, oncologic). Use objective, standardized pain scales and trust patient self-report.
— False beliefs about biological differences (skin thickness, pain tolerance) persist among trainees — recognize and counter.
Step 3 management: If a vignette shows a Black patient with sickle cell vaso-occlusive crisis being given suboptimal opioid doses or delayed analgesia, the correct next step is prompt, weight-based IV opioid per individualized pain plan within 30–60 minutes, not "reassess in 2 hours" or switch to NSAIDs alone. Recognize bias-driven undertreatment as a patient safety event.
— eGFR: 2021 NKF-ASN task force recommends race-free CKD-EPI 2021 equation (creatinine ± cystatin C). The prior "race coefficient" overestimated GFR in Black patients, delaying CKD staging, nephrology referral, and transplant listing.
— VBAC calculator: race/ethnicity terms removed (2021) — prior version lowered predicted VBAC success for Black and Hispanic women, steering them toward repeat cesarean.
— STONE score, UTI calculator, ASCVD pooled cohort equations: under active reassessment; ASCVD risk in South Asian and certain Hispanic subgroups is underestimated — use clinician judgment, CAC scoring as tiebreaker.
— Pulmonary function (spirometry): GLI-2022 race-neutral reference equations now recommended; race-specific equations historically underdiagnosed restrictive disease and reduced disability/transplant eligibility in Black patients.
— Cardiac surgery (STS) risk, kidney donor profile index: revisions ongoing.
— Benign ethnic neutropenia (Duffy-null phenotype) — common in West African ancestry; do not delay chemo or label as "unsafe ANC" using standard cutoffs alone.
— Hemoglobin/hematocrit reference ranges differ; do not miss true anemia by assuming "baseline low."
— Confirm patient received age-appropriate USPSTF screens (colorectal at 45, lung CT, mammography, cervical, HepC, HIV) — disparities often originate at the screening offer, not patient refusal.
Board pearl: If the stem gives a Black patient with eGFR calculated using an old race-adjusted equation placing them just above transplant-listing threshold, the correct action is recalculate with the 2021 race-free CKD-EPI equation and refer to nephrology/transplant.
— Healthy People 2030 disparity objectives and leading health indicators
— CDC Social Vulnerability Index (SVI) — 4 themes: socioeconomic, household composition, minority/language, housing/transportation; used to direct outreach (e.g., vaccine equity)
— Area Deprivation Index (ADI) — neighborhood disadvantage at census block level
— CMS Z-codes (Z55–Z65) — ICD-10 codes capturing SDOH (housing, food, education); document these to enable care coordination and risk adjustment
— Stratify quality metrics (HbA1c <7%, BP <140/90, screening rates) by race, ethnicity, language, payer — disparities invisible in aggregate become actionable when disaggregated
— REaL + SOGI data collection (Race, Ethnicity, Language, Sexual Orientation, Gender Identity) per IOM standard
Key distinction: Measuring disparity (descriptive epidemiology) is not the same as addressing structural cause. Step 3 favors answers that pair measurement with a targeted, system-level intervention (e.g., embedding a doula program, expanding postpartum Medicaid to 12 months, language-concordant discharge instructions).
— Maternal mortality: Non-Hispanic Black women 3× and AI/AN women 2× higher pregnancy-related mortality vs White women; gap persists across income and education
— Infant mortality: Black infants 2× rate of White infants; preterm birth and SUID drivers
— Cardiovascular: Black adults — earlier-onset HTN, higher stroke mortality, lower rates of guideline-directed HF therapy and ICD placement
— Diabetes: Higher lower-extremity amputation rates in Black and Hispanic patients; lower CGM/insulin pump uptake despite equal benefit
— Cancer: Black men — highest prostate cancer mortality; Black women — higher breast cancer mortality despite lower incidence (delayed dx, less access to trimodal therapy, triple-negative biology partly)
— Mental health: Black patients more often dx with schizophrenia vs mood disorder for identical symptoms; lower access to outpatient psychiatry
— Pain/SCD: systemic undertreatment
— LGBTQ+ and AI/AN populations: higher suicide, substance use, lower preventive care uptake
— Individual: trust-building, teach-back, shared decision-making
— Interpersonal: care teams that look like the community; CHWs, doulas, peer navigators
— Organizational: bias training with accountability metrics, REaL data stratification, race-conscious quality improvement
— Community: partnerships with FQHCs, schools, faith-based orgs
— Policy: Medicaid expansion, paid sick leave, housing-first
Step 3 management: For a Black pregnant patient in a high-mortality region, the highest-yield interventions are doula/CHW support, standardized maternal early warning criteria, postpartum Medicaid extension to 12 months, and a scheduled 1–3 week postpartum visit (not the historical 6-week-only visit).
— Black and Hispanic patients with HFrEF less likely to receive quadruple therapy (ARNI, evidence-based BB, MRA, SGLT2i)
— Lower rates of DOACs vs warfarin in Black AFib patients; lower statin intensity post-MI
— Lower buprenorphine/naltrexone for OUD; higher methadone-only or no MAT
— Lower SGLT2i and GLP-1 RA prescribing in Black diabetics with same indications
— Lower inhaled biologics for severe asthma
— Historical "BiDil" (isosorbide dinitrate–hydralazine) approved in self-identified Black HFrEF patients as add-on to GDMT, not as substitute. Modern practice: ensure ARNI/BB/MRA/SGLT2i first; H-ISDN is adjunct.
— ACEi/ARB: efficacy in Black patients without proteinuria/CKD is somewhat lower as monotherapy for BP, but strongly indicated when CKD, proteinuria, HF, or post-MI present — do not withhold.
— Thiazides and CCBs are preferred initial BP agents in Black adults without compelling indications (JNC/ACC guidance).
— 90-day fills, mail-order, $4 generics, patient assistance programs
— Language-concordant labels, pictographs for low literacy
— Address pharmacy deserts via mail order or in-clinic dispensing
— Screen for cost-related non-adherence: "In the last year, have you skipped or stretched any medications because of cost?"
Board pearl: A Black patient post-MI with HFrEF (EF 30%) and CKD-3 should receive ARNI + evidence-based BB + MRA + SGLT2i + statin + DAPT — same as any patient. Failure to prescribe these is a disparity, not a clinical judgment call.
— Universal SDOH screening with closed-loop referral to social work, CHWs, legal partnerships (Medical-Legal Partnership for housing/benefits issues)
— Patient navigators and CHWs: proven to improve cancer screening, BP control, prenatal care attendance in minoritized populations
— Group prenatal care (CenteringPregnancy): reduces preterm birth in Black women
— Doulas: reduce cesarean, improve breastfeeding, improve patient experience — coverage expanding under Medicaid
— Language access: professional interpreters in person/video/phone — improves outcomes, reduces readmissions; never use minors as interpreters (ethical and legal violation)
— Diverse workforce: race-concordant care associated with improved communication and, in some studies, better outcomes (Black newborns cared for by Black physicians have lower mortality)
— Implicit bias training paired with structural change — training alone has limited effect without accountability
— Medicaid expansion → improved coverage, screening, maternal outcomes
— Postpartum Medicaid extension to 12 months (now adopted by most states)
— WIC, SNAP, EITC: associated with improved infant and child health
— Lead abatement programs in older housing
— Housing First initiatives for people experiencing homelessness
— Investing in FQHCs (sliding-scale, comprehensive primary care; 340B drug pricing)
— Stratify metrics by race/ethnicity/language; set equity-specific targets, not just overall improvement (avoid "lifting the floor while keeping the gap")
CCS pearl: On a CCS-style case with a low-income, uninsured, or LEP patient, order "social work consult," "case management," "interpreter services," and "patient education with teach-back" alongside medical orders — these advance the clock and improve simulated outcomes the way procedures do in cardiology cases.
— Higher prevalence of multimorbidity at younger chronological ages → adjust screening and prevention accordingly (do not under-screen based on age alone)
— Polypharmacy intersects with cost barriers → Beers Criteria review, deprescribing, Medicare Part D Extra Help/LIS enrollment
— Lower rates of advance care planning documentation in Black and Hispanic older adults — driven partly by justified mistrust (Tuskegee, coercive sterilizations, current under-treatment); approach with cultural humility, involve family/clergy as patient prefers
— Lower hospice utilization; higher rates of aggressive end-of-life care — not necessarily a disparity to "fix" if it reflects informed preference, but ensure fully informed choice
— Race-free eGFR (2021) has increased CKD staging accuracy in Black patients → ensure timely nephrology referral at eGFR <30, vascular access planning, transplant evaluation
— Black patients historically waited longer for kidney transplants; UNOS now allows retroactive waitlist time adjustment for Black patients disadvantaged by old eGFR equations — testable factoid
— Living donor disparities: lower rates among Black recipients; address via culturally tailored education
— Hispanic patients have higher NAFLD prevalence (partly PNPLA3 variant, partly metabolic); ensure equitable access to GLP-1 RA, bariatric referral, HCC surveillance
— HCV: birth-cohort and universal screening; Black patients historically less likely to receive DAA therapy — address payer prior-auth barriers
Step 3 management: A 58-year-old Black man with prior eGFR 22 (old race-adjusted formula) — recompute with 2021 CKD-EPI; if reclassified to lower eGFR or different stage, adjust transplant waitlist time, initiate access planning, and refer for evaluation now.
— Black, AI/AN, and rural women: highest maternal mortality
— Leading preventable causes: hemorrhage, hypertensive disorders, cardiomyopathy, mental health/overdose, infection
— Listen and act on symptoms (headache, SOB, chest pain, severe pain) — bias-driven dismissal is a recurring root cause in MMRC reviews
— Implement standardized bundles (AIM bundles for hemorrhage, hypertension, sepsis, mental health)
— Postpartum visit at 1–3 weeks, comprehensive visit by 12 weeks; screen PPD, BP, contraception, chronic disease handoff
— Asthma: Black and Puerto Rican children — highest morbidity/mortality; address housing triggers, controller adherence, action plans in preferred language
— Lead screening: targeted in Medicaid-enrolled and high-risk ZIP codes at 12 and 24 months; capillary screen with venous confirmation if ≥3.5 µg/dL (current CDC reference value)
— ADHD: Black and Hispanic children under-diagnosed and under-treated; school-based collaborative care helps
— Title VI mandates language access at federally funded facilities; certified medical interpreters required
— "Public charge" fear → patients may avoid enrolling eligible children in Medicaid/CHIP; reassure that WIC, emergency Medicaid, CHIP for children, and most safety-net services do not count
— Refugee health screening per CDC domestic medical exam guidelines
— Higher rates of anxiety, depression, substance use, HIV (esp. Black/Latinx MSM and trans women)
— PrEP disparities: lower uptake in Black/Latinx populations despite higher incidence — actively offer
— Gender-affirming care access varies by state — know referral pathways
Board pearl: A postpartum Black woman at 10 days with headache, BP 158/102, and "feeling off" — treat as severe-range hypertension, admit/observe, IV antihypertensive, magnesium for preeclampsia with severe features. Do not dismiss as "anxiety" or "normal postpartum."
— Preventable maternal deaths and severe maternal morbidity (hemorrhage, eclampsia, peripartum cardiomyopathy)
— Excess premature CV mortality, stroke, ESRD
— Higher rates of avoidable amputations, blindness, dialysis from poorly controlled diabetes
— Late-stage cancer presentations and higher case-fatality
— Excess infant mortality, preterm birth, SUID
— Untreated mental illness, criminal-justice involvement instead of psychiatric care
— Diagnostic error from anchoring on race-based assumptions (e.g., attributing chest pain in a young Black woman to anxiety; missing SLE, PE, dissection)
— Pain undertreatment (especially sickle cell, post-op, oncologic)
— Coercion in reproductive care: historic forced sterilizations (Relf v. Weinberger, Puerto Rico, ICE detention reports); modern echoes in differential LARC counseling
— Discharge to unsafe environments without adequate planning → readmission
— Restraint and security calls disproportionately used on Black patients in EDs and inpatient psych
— Chronic exposure to discrimination → elevated cortisol, inflammation, telomere shortening, earlier onset of chronic disease — biologically plausible mechanism linking racism to outcomes independent of SES
— Historical events (Tuskegee, J. Marion Sims, Henrietta Lacks, eugenics laws) and ongoing experiences fuel justified mistrust — the burden is on the system to earn trust, not on the patient to "be more compliant"
Key distinction: "Health disparity" describes the outcome; "health inequity" specifies that the disparity is unjust and avoidable. The Step 3 examinee should use inequity when the cause is rooted in structural factors that policy and clinical practice can change.
— File through hospital incident reporting / patient safety event system whenever a clinical outcome is plausibly worsened by bias, language access failure, or SDOH-related discharge failure
— Examples: undertreated sickle cell pain → re-presentation; LEP patient discharged without interpreted instructions → medication error/readmission; missed maternal warning signs → ICU admission or death
— Maternal Mortality Review Committees (state-level), Severe Maternal Morbidity (SMM) reviews, AIM bundles — escalate any near-miss
— Disparity dashboards stratifying readmissions, mortality, HCAHPS by race/language
— Root Cause Analysis (RCA) for any event with possible bias contribution — explicitly include equity lens in the "5 Whys"
— Patient reports discriminatory treatment → acknowledge, document, escalate to charge nurse/medical director, offer patient advocate/ombudsman
— Suspected coercion in reproductive or end-of-life decisions → ethics consult
— Persistent uncontrolled chronic disease in a high-disparity group → social work, CHW, pharmacy, care management referrals
— Lower threshold to admit or extend observation in patients facing unsafe discharge environments (homelessness, no medication access, domestic violence, IPV) — document the medical necessity tied to safe discharge planning
— Engage case management early; involve medical-legal partnerships for benefits, housing, immigration
CCS pearl: When a CCS-style case involves a non–English-speaking patient or one with clear social barriers, order "interpreter services," "social work consult," "case management," and "patient education" early. Skipping these in favor of medical orders alone is treated as deficient management.
— Access barriers (insurance, geography, transportation, pharmacy desert) → expand coverage, mail-order pharmacy, telehealth, mobile clinics, FQHC referral
— Affordability (copays, deductibles, medication cost) → generics, $4 lists, 340B, patient assistance, charity care, switching to lower-tier formulary
— Health literacy and language → teach-back, plain language at 5th-grade level, professional interpreters, translated written materials
— Cultural/religious context → cultural humility, community health workers, faith-based partnerships, dietary accommodations
— Mistrust (historical and current) → continuity, transparency, race-concordant care when possible, community partnerships, acknowledge history without defensiveness
— Discrimination in the encounter (provider bias) → bias training, scripted intake, decision support, accountability metrics
— Competence implies a finite skill set — limited, can encourage stereotyping
— Humility is a lifelong reflective practice acknowledging power differentials and patient expertise about their own life — current preferred framework
— Implicit: unconscious associations (measured by IAT); ubiquitous; mitigated by individuation, perspective-taking, structural decision support
— Explicit: conscious; addressed through professionalism standards, disciplinary action
— SDOH = conditions in which people live (the what)
— Structural racism = the historical and ongoing why certain populations are systematically exposed to adverse SDOH
Key distinction: Naming a problem as "SDOH" without naming racism as an upstream driver can obscure the policy and accountability response. Step 3 increasingly tests this nuance — choose answers that pair SDOH screening with structural/system-level remediation, not just individual patient education.
— Socioeconomic status: correlates with but does not explain racial disparities — gaps persist at every income level (Black college-educated women still have higher maternal mortality than White women without high school diplomas)
— Rurality: maternity care deserts, hospital closures, fewer specialists — overlaps with race in the rural South, Appalachia, tribal lands
— Disability: disabled patients (especially BIPOC disabled) face compounded barriers in exam rooms, equipment, communication
— Gender and gender identity: women's pain dismissed more often; trans patients face provider refusal, misgendering
— Sexual orientation: LGB patients — disparities in preventive care, mental health
— Immigration status: fear of deportation/public charge limits care-seeking
— Incarceration history: poor handoff at release → loss of chronic disease control, opioid overdose risk in first 2 weeks
— Language: independently associated with worse outcomes when interpreters unused
— Multiply marginalized patients (e.g., Black trans woman, undocumented Latina with disability) experience compounding, not merely additive, disadvantage
— Interventions must be tailored, not generic
— Ancestry-linked pharmacogenomics (HLA-B5701 before abacavir; HLA-B1502 before carbamazepine in Asian ancestry) — these are genetic markers, not "race-based" prescribing
— Sickle cell, Tay-Sachs, BRCA founder mutations: offer testing based on ancestry-informed risk, not assume by race
Board pearl: Race ≠ ancestry ≠ genetics. When a stem hints at pharmacogenomics or hereditary disease, the trigger should be specific ancestry or family history, not self-reported race. Self-reported race remains useful for measuring inequity, not for predicting biology.
— Medication reconciliation with patient and caregiver, in preferred language, with teach-back
— Verify affordability of each Rx; switch to generics or $4 list as needed; arrange 90-day fills or mail order
— Confirm pharmacy access (open, in network, near home/transit)
— Follow-up appointment scheduled before discharge (warm handoff > "call to schedule")
— Transportation to follow-up arranged (Medicaid NEMT, ride-share programs)
— DME, home health, food delivery (Meals on Wheels, produce Rx) ordered as needed
— Behavioral health and substance use linkages active before discharge
— Caregiver and housing stability addressed
— Maintain race/ethnicity/language-stratified registries for chronic disease panels
— Use panel management and pop-health outreach to close gaps proactively (don't rely on patients to return)
— Annual SDOH re-screen
— Standing orders for guideline-recommended preventive services (vaccines, screening) reduce bias-driven omissions
— Address barriers to flu, COVID, pneumococcal, RSV, HPV, shingles vaccines — same-day vaccination, evening hours, mobile units
— Colorectal screening at age 45 (USPSTF); reduce disparities via mailed FIT, patient navigation
— Lung cancer screening: 2021 USPSTF lowered age to 50 and pack-year threshold to 20, expanding eligibility among Black smokers historically excluded
Step 3 management: Before discharging a low-income patient post-MI, ensure they leave with affordable DAPT, statin, BB, ACEi/ARB, cardiac rehab referral, 1–2 week follow-up, transportation plan, and tobacco cessation support. Skipping cardiac rehab referral — a known disparity — is the wrong answer.
— Postpartum: initial contact within 3 weeks (not 6), comprehensive visit by 12 weeks; BP check at 3–7 days for hypertensive disorders
— Post-hospitalization (HF, COPD, MI): 7-day follow-up reduces readmissions; equity-focused programs prioritize high-SVI patients
— Diabetes: quarterly HbA1c until controlled; annual eye, foot, urine albumin/creatinine; CGM access for type 1 and selected type 2
— HTN: home BP monitoring with cellular-enabled cuffs improves control in Black patients (best-in-class evidence from clinic-based programs)
— Teach-back every visit for any new diagnosis or medication
— Plain-language, translated, pictographic materials
— Shared decision-making decision aids — improve informed choice and reduce disparities in PSA screening, lung cancer screening, contraception, HF device decisions
— Motivational interviewing for behavior change; avoid stigmatizing language ("noncompliant," "drug-seeker," "frequent flyer")
— Track HCAHPS, PREMs stratified by race/language; act on gaps
— Solicit patient feedback on perceived discrimination; close the loop
— Continuity bridge between clinic and home; high-yield Step 3 answer for chronic disease control and maternal outcomes in minoritized populations
— Audio-only visits often necessary for patients without broadband; CMS continues coverage flexibility
— Provide tech support, language interpretation in virtual visits
CCS pearl: When the CCS clock advances and a patient hasn't returned, the right move is often outreach via care manager/CHW rather than waiting passively. Building proactive outreach into the plan reflects modern population health practice and is rewarded in Step 3 management vignettes.
— Justice — distributive justice demands attention to inequity; "treating everyone the same" is not equitable if baseline access differs
— Beneficence and non-maleficence — failing to address bias-driven undertreatment causes harm
— Autonomy — requires informed consent in patient's preferred language with adequate literacy; coercion in reproductive or end-of-life decisions violates autonomy
— Title VI, Civil Rights Act 1964 — prohibits discrimination based on race, color, national origin in federally funded programs; basis for language access requirements
— Section 1557, ACA — nondiscrimination in health programs; includes sex (incl. gender identity per current rule), disability, age, race
— ADA — disability accommodations including communication (ASL interpreters, accessible exam tables)
— EMTALA — universal stabilization regardless of insurance/status; bias-driven turfing is a violation
— HIPAA — protects against disclosure to immigration enforcement except under specific legal process; reassure patients about confidentiality
— LEP patient → consent obtained via certified interpreter, not family member or untrained staff; document interpreter ID
— Health-literacy-mismatched consent → use teach-back; if patient cannot articulate risks/benefits/alternatives, consent is not informed
— Reproductive procedures (sterilization, LARC) → ensure no coercion; Medicaid requires 30-day waiting period and specific consent form for sterilization (post–Relf v. Weinberger protections)
— Suspected child abuse, elder abuse, certain communicable diseases — mandatory regardless of immigration status; do not threaten or report immigration status
— IPV — most states do not require reporting except certain injuries; respect autonomy
— Discharging an LEP, low-literacy, or housing-insecure patient without coordinated supports is a patient safety event; document the equity-focused discharge plan
Board pearl: Using a 12-year-old daughter as Spanish interpreter for her mother's hysterectomy consent is both a Title VI violation and an informed-consent failure — the correct answer is always a professional medical interpreter, documented in the chart.
— Black maternal mortality: ~3× White; AI/AN ~2×
— Black infant mortality: ~2× White
— Pulse oximeter occult hypoxemia: ~3× more common in Black ICU patients
— Postpartum Medicaid extension: 12 months (most states adopted)
— USPSTF colorectal screening: age 45 (2021)
— Lung cancer screening LDCT: age 50–80, 20 pack-years, current or quit within 15 years
— Cervical cancer screening: ages 21–65 per current USPSTF (HPV testing primary 30–65)
— eGFR (CKD-EPI 2021), VBAC calculator, spirometry (GLI-2022)
— HLA-B*5701 → abacavir hypersensitivity
— HLA-B*1502 → carbamazepine SJS in Asian ancestry
— G6PD deficiency → rasburicase, dapsone, primaquine caution
— Tuskegee Syphilis Study (1932–1972) — basis for Belmont Report and modern IRB protections
— Henrietta Lacks — informed consent and tissue use
— Relf v. Weinberger (1973) — sterilization consent rules
— Redlining (1930s HOLC maps) → contemporary asthma, lead, heat-related illness clusters
— Healthy People 2030, CDC SVI, Area Deprivation Index, Z-codes (Z55–Z65), AIM bundles, IHI Triple/Quadruple/Quintuple Aim (Quintuple Aim added health equity)
Key distinction: The Quintuple Aim (vs Triple/Quadruple) is a 2022 update by Nundy/Berwick adding equity as an explicit aim — expect this on board questions about value-based care and population health.
— Black patient near a clinical decision threshold using a race-adjusted equation (eGFR, VBAC, spirometry). Answer: recalculate with race-free equation; act on the new result (refer to nephrology/transplant, offer TOLAC, restage lung disease).
— Young Black patient with sickle cell crisis, ED triage delays, low-dose analgesia. Answer: prompt weight-based IV opioid per individualized plan within 30–60 minutes; recognize bias.
— Patient missing appointments / not refilling meds. Answer: screen SDOH (transportation, cost, housing, language), connect to CHW/social work, switch to mail-order or $4 generics, schedule with interpreter; do NOT discharge from practice or label as nonadherent.
— Black postpartum woman with headache, BP elevated, SOB. Answer: evaluate for severe-range HTN/preeclampsia/PE/cardiomyopathy; treat aggressively; do not attribute to anxiety.
— LEP patient with family member interpreting for procedure consent. Answer: use certified medical interpreter (Title VI, informed consent).
— Practice notes disparate HbA1c control by race. Answer: stratified registry + CHW outreach + group visits + medication access program — not "more provider education alone."
— Homeless or housing-insecure patient post-admission. Answer: social work, medical respite, MAT linkage if SUD, transportation, follow-up scheduled, naloxone Rx if opioid risk.
— Black HFrEF patient post-MI not on full GDMT. Answer: initiate ARNI/BB/MRA/SGLT2i, statin; add H-ISDN if still symptomatic on max GDMT.
Step 3 management: When two answer choices are clinically reasonable, prefer the one that addresses an upstream structural barrier or guideline gap rather than escalating individual pharmacotherapy without addressing access. The exam rewards thinking like a population health–oriented PCP.
Structural racism is a modifiable driver of poor health outcomes, and the Step 3 clinician's job is to recognize it in the encounter, remove it from algorithms, and replace it with equitable, system-level action.
Master this lens and the exam — and your patients — will be measurably better served.